European Archives - Page 51 of 1165 - European Medical Journal

Major Treatment Gap for Drug-Resistant Infections in Low/Middle-Income Countries

A major treatment gap for life-threatening carbapenem-resistant Gram-negative bacterial infections has been revealed across eight low- and middle-income countries.

Breakthrough in Human Antibodies for Snakebite Treatment

Each year, up to 138,000 people die and around 400,000 more are left permanently disabled from snakebites.

Trump’s drug pricing order hits pharma stocks

Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms.

Eosinophilic Inflammation Identifies Treatable Subtype of COPD

A new study identifies airway eosinophilia as a distinct, corticosteroid-responsive subtype of COPD, marked by heightened type 2 inflammation and gene expression changes.

Preparing for the Next Outbreak: Interview with Maria Zambon

The UK Health Security Agency (UKHSA) is an executive government agency, sponsored by the Department of Health and Social…

Cannabis in Pregnancy Linked to Poor Neonatal Outcomes

Cannabis use during pregnancy significantly increases the risk of low birth weight, preterm birth, and other poor neonatal outcomes, even after adjusting for tobacco use, a major meta-analysis finds.

Heart Scans May Guide Life-Saving Treatments for Coronary Artery Disease

Imaging findings help guide targeted medical therapy for coronary artery disease, improving survival in selected patient groups.

Tumour Evolution in Constitutional Mismatch Repair Deficiency

A new genomic study has revealed diverse and treatment-influenced mutational patterns in tumours associated with Constitutional Mismatch Repair Deficiency …

New Relief for Children with Seasonal Eye Allergies

Researchers have explored the potential of intense pulsed light therapy as a supplementary treatment for refractory SAC.

Resolved Hepatitis B Infection Linked to Increased Depression Risk

The study raises important concerns about the long-term mental health of individuals with resolved HBV infection.